Indivior Pharmaceuticals Inc (INDV) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Indivior Pharmaceuticals Inc in 2026. The next earnings report is expected on October 29, 2026.
Next earnings date
29 Oct 2026
In 70 days
EPS estimate
0.95
Revenue estimate
318.7M
Past earnings
Latest earnings analysis
Indivior Pharmaceuticals beat consensus estimates in its latest earnings report, with EPS of $1.15 coming in 29.3% above expectations and revenue of $343 million exceeding estimates by 11.5%. In the previous report, both EPS and revenue also came in ahead of expectations.
No dividend history available.
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Indivior Pharmaceuticals Inc (INDV) is scheduled to report earnings on October 29, 2026.
Indivior Pharmaceuticals Inc (INDV) last reported earnings on August 4, 2026.
Indivior Pharmaceuticals Inc (INDV) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.